Katy Pellow

Professional Qualifications:
European Patent Attorney
Chartered Patent Attorney

Academic qualifications:
M.Chem. Chemistry, Cardiff University
Ph.D. Chemistry, University of Bristol

Katy joined Abel + Imray LLP in 2018 and is based in our Bath office. She is a member of our ChemBio team and works with clients across a range of chemical applications including catalysis, polymers, lubricants, fuels, skincare, post- and probiotics, and inhalable therapeutics. She has experience of drafting, prosecuting and opposing patent applications in the UK and Europe, and managing clients’ portfolios worldwide. Katy also provides freedom to operate opinions.

Katy gained her PhD from the University of Bristol through the Chemical Synthesis Centre for Doctoral Training. At the beginning of her doctoral training, Katy carried out several short research projects in the areas of carbohydrate chemistry, organocatalysis, PDMS polymers, and homogeneous catalysis. Having gained practical experience across a range of synthetic chemistry areas, she chose to carry out her research project on the development of homogeneous transition metal catalysts for upgrading bioethanol to butanol. Butanol shows promise as an alternative to traditional petrochemical fuels and it is through her research that Katy has gained an interest in biofuels, sustainable energy and renewable technology.

She is experienced in drafting and prosecuting patent applications relating to cosmetics, skincare products, and probiotic and postbiotic supplements. Katy has assisted a leading multinational cosmetic company with the management of their global patent portfolio.

Katy has gained expertise in the field of inhalable therapeutics and inhaler devices through working with a respiratory drug delivery specialist. Katy’s knowledge ranges from inhaler devices, such as pressurised metered dose inhalers (pMDIs) and dry powder inhalers (DPI), to formulation development and stabilisation. She is also familiar with drug delivery analysis such as aerodynamic particle size distribution and delivered dose testing, which may be used to approximate how much drug is delivered and where it deposits in the lung.

A significant proportion of her work relates to polymers, especially polyethylene and polypropylene polymers, petrochemicals, reactor technology, and catalysis, including zeolites and metallocenes.

Katy is a member of the Royal Society of Chemistry and a committee member of the Royal Society of Chemistry Law Group. She has created and facilitated workshops and IP training sessions including for Cardiff University and the Royal Society of Chemistry.